APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Contract Manufacturing and Contract

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical Contract Manufacturing and Contract Market Outlook and Growth Opportunities 2026

31 December 2025209 pages

Choose your research edition.

Industry ResearchPharmaceutical Contract Manufacturing and Contract Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Contract Manufacturing and Contract Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Contract Manufacturing and Contract Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Contract Manufacturing and Contract Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Contract Manufacturing and Contract Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

North America is the largest consumption place, with a consumption market share nearly 35% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 23%.

This report provides an overview of the global Pharmaceutical Contract Manufacturing and Contract market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Pharmaceutical Contract Manufacturing and Contract and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical Contract Manufacturing and Contract revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Contract Manufacturing and Contract market.

Pharmaceutical Contract Manufacturing and Contract Segment by Company

Catalent

Thermo Fisher Scientific

Lonza

Boehringer Ingelheim

Fareva

Recipharm

Aenova

AbbVie

Baxter

Nipro Corp

Sopharma

Famar

Vetter

Shandong Xinhua

Piramal

Mylan

Dr. Reddy’s

Zhejiang Hisun

Zhejiang Huahai

Jubilant

Pharmaceutical Contract Manufacturing and Contract Segment by Type

Oral

Injectable

API

Other

Pharmaceutical Contract Manufacturing and Contract Segment by Application

Small Medium Enterprise

Large Enterprise

Pharmaceutical Contract Manufacturing and Contract Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical Contract Manufacturing and Contract status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical Contract Manufacturing and Contract key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical Contract Manufacturing and Contract breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical Contract Manufacturing and Contract market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical Contract Manufacturing and Contract significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical Contract Manufacturing and Contract competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Contract Manufacturing and Contract market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Contract Manufacturing and Contract and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Contract Manufacturing and Contract.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Contract Manufacturing and Contract industry.

Chapter 3: Detailed analysis of Pharmaceutical Contract Manufacturing and Contract company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical Contract Manufacturing and Contract in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical Contract Manufacturing and Contract in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical Contract Manufacturing and Contract Industry Trends Table 2. Pharmaceutical Contract Manufacturing and Contract Industry Drivers Table 3. Pharmaceutical Contract Manufacturing and Contract Industry Opportunities and Challenges Table 4. Pharmaceutical Contract Manufacturing and Contract Industry Restraints Table 5. Global Pharmaceutical Contract Manufacturing and Contract Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical Contract Manufacturing and Contract Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical Contract Manufacturing and Contract Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical Contract Manufacturing and Contract Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical Contract Manufacturing and Contract Company, Product Type & Application Table 10. Global Pharmaceutical Contract Manufacturing and Contract Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical Contract Manufacturing and Contract by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Table 15. Significant Companies of Injectable Table 16. Significant Companies of API Table 17. Significant Companies of Other Table 18. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type (2021-2026) Table 22. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Small Medium Enterprise Table 24. Significant Companies of Large Enterprise Table 25. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application (2021-2026) Table 29. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application (2027-2032) Table 30. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Region (2021-2026) Table 33. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Region (2027-2032) Table 35. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Market Share by Country (2021-2026) Table 38. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Market Share by Country (2027-2032) Table 40. Catalent Company Information Table 41. Catalent Business Overview Table 42. Catalent Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Catalent Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 44. Catalent Recent Development Table 45. Thermo Fisher Scientific Company Information Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 49. Thermo Fisher Scientific Recent Development Table 50. Lonza Company Information Table 51. Lonza Business Overview Table 52. Lonza Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Lonza Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 54. Lonza Recent Development Table 55. Boehringer Ingelheim Company Information Table 56. Boehringer Ingelheim Business Overview Table 57. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 59. Boehringer Ingelheim Recent Development Table 60. Fareva Company Information Table 61. Fareva Business Overview Table 62. Fareva Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Fareva Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 64. Fareva Recent Development Table 65. Recipharm Company Information Table 66. Recipharm Business Overview Table 67. Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Recipharm Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 69. Recipharm Recent Development Table 70. Aenova Company Information Table 71. Aenova Business Overview Table 72. Aenova Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Aenova Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 74. Aenova Recent Development Table 75. AbbVie Company Information Table 76. AbbVie Business Overview Table 77. AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. AbbVie Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 79. AbbVie Recent Development Table 80. Baxter Company Information Table 81. Baxter Business Overview Table 82. Baxter Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Baxter Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 84. Baxter Recent Development Table 85. Nipro Corp Company Information Table 86. Nipro Corp Business Overview Table 87. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 89. Nipro Corp Recent Development Table 90. Sopharma Company Information Table 91. Sopharma Business Overview Table 92. Sopharma Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Sopharma Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 94. Sopharma Recent Development Table 95. Famar Company Information Table 96. Famar Business Overview Table 97. Famar Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Famar Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 99. Famar Recent Development Table 100. Vetter Company Information Table 101. Vetter Business Overview Table 102. Vetter Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Vetter Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 104. Vetter Recent Development Table 105. Shandong Xinhua Company Information Table 106. Shandong Xinhua Business Overview Table 107. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 109. Shandong Xinhua Recent Development Table 110. Piramal Company Information Table 111. Piramal Business Overview Table 112. Piramal Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Piramal Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 114. Piramal Recent Development Table 115. Mylan Company Information Table 116. Mylan Business Overview Table 117. Mylan Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Mylan Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 119. Mylan Recent Development Table 120. Dr. Reddy’s Company Information Table 121. Dr. Reddy’s Business Overview Table 122. Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 123. Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 124. Dr. Reddy’s Recent Development Table 125. Zhejiang Hisun Company Information Table 126. Zhejiang Hisun Business Overview Table 127. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 128. Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 129. Zhejiang Hisun Recent Development Table 130. Zhejiang Huahai Company Information Table 131. Zhejiang Huahai Business Overview Table 132. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 133. Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 134. Zhejiang Huahai Recent Development Table 135. Jubilant Company Information Table 136. Jubilant Business Overview Table 137. Jubilant Pharmaceutical Contract Manufacturing and Contract Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 138. Jubilant Pharmaceutical Contract Manufacturing and Contract Product Portfolio Table 139. Jubilant Recent Development Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Pharmaceutical Contract Manufacturing and Contract Product Image Figure 2. Global Pharmaceutical Contract Manufacturing and Contract Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical Contract Manufacturing and Contract Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Image Figure 8. Injectable Image Figure 9. API Image Figure 10. Other Image Figure 11. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type (2021-2032) Figure 14. Small Medium Enterprise Image Figure 15. Large Enterprise Image Figure 16. Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application (2021-2032) Figure 19. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injectable
  • API
  • Other
Applications
  • Small Medium Enterprise
  • Large Enterprise
Companies covered
  • Catalent
  • Thermo Fisher Scientific
  • Lonza
  • Boehringer Ingelheim
  • Fareva
  • Recipharm
  • Aenova
  • AbbVie
  • Baxter
  • Nipro Corp
  • Sopharma
  • Famar
  • Vetter
  • Shandong Xinhua
  • Piramal
  • Mylan
  • Dr. Reddy’s
  • Zhejiang Hisun
  • Zhejiang Huahai
  • Jubilant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical Contract Manufacturing and Contract Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical Contract Manufacturing and Contract Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical Contract Manufacturing and Contract Market Dynamics
  1. 2.1 Pharmaceutical Contract Manufacturing and Contract Industry Trends
  2. 2.2 Pharmaceutical Contract Manufacturing and Contract Industry Drivers
  3. 2.3 Pharmaceutical Contract Manufacturing and Contract Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Contract Manufacturing and Contract Industry Restraints
3 Pharmaceutical Contract Manufacturing and Contract Market by Company
  1. 3.1 Global Pharmaceutical Contract Manufacturing and Contract Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical Contract Manufacturing and Contract Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical Contract Manufacturing and Contract Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical Contract Manufacturing and Contract Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical Contract Manufacturing and Contract Company Product Type and Application
  6. 3.6 Global Pharmaceutical Contract Manufacturing and Contract Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical Contract Manufacturing and Contract Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical Contract Manufacturing and Contract Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Contract Manufacturing and Contract Market by Type
  1. 4.1 Pharmaceutical Contract Manufacturing and Contract Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injectable
  4. 4.1.3 API
  5. 4.1.4 Other
  6. 4.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Type
  7. 4.2.1 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type (2021-2032)
5 Pharmaceutical Contract Manufacturing and Contract Market by Application
  1. 5.1 Pharmaceutical Contract Manufacturing and Contract Application Introduction
  2. 5.1.1 Small Medium Enterprise
  3. 5.1.2 Large Enterprise
  4. 5.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Application
  5. 5.2.1 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Application (2021-2032)
  7. 5.2.3 Global Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application (2021-2032)
6 Pharmaceutical Contract Manufacturing and Contract Regional Value Analysis
  1. 6.1 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Contract Manufacturing and Contract Country-level Value Analysis
  1. 7.1 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical Contract Manufacturing and Contract Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical Contract Manufacturing and Contract Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical Contract Manufacturing and Contract Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Catalent
  2. 8.1.1 Catalent Company Information
  3. 8.1.2 Catalent Business Overview
  4. 8.1.3 Catalent Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Catalent Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  6. 8.1.5 Catalent Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Lonza
  14. 8.3.1 Lonza Company Information
  15. 8.3.2 Lonza Business Overview
  16. 8.3.3 Lonza Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lonza Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  18. 8.3.5 Lonza Recent Developments
  19. 8.4 Boehringer Ingelheim
  20. 8.4.1 Boehringer Ingelheim Company Information
  21. 8.4.2 Boehringer Ingelheim Business Overview
  22. 8.4.3 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Boehringer Ingelheim Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  24. 8.4.5 Boehringer Ingelheim Recent Developments
  25. 8.5 Fareva
  26. 8.5.1 Fareva Company Information
  27. 8.5.2 Fareva Business Overview
  28. 8.5.3 Fareva Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fareva Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  30. 8.5.5 Fareva Recent Developments
  31. 8.6 Recipharm
  32. 8.6.1 Recipharm Company Information
  33. 8.6.2 Recipharm Business Overview
  34. 8.6.3 Recipharm Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Recipharm Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  36. 8.6.5 Recipharm Recent Developments
  37. 8.7 Aenova
  38. 8.7.1 Aenova Company Information
  39. 8.7.2 Aenova Business Overview
  40. 8.7.3 Aenova Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Aenova Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  42. 8.7.5 Aenova Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 Baxter
  50. 8.9.1 Baxter Company Information
  51. 8.9.2 Baxter Business Overview
  52. 8.9.3 Baxter Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Baxter Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  54. 8.9.5 Baxter Recent Developments
  55. 8.10 Nipro Corp
  56. 8.10.1 Nipro Corp Company Information
  57. 8.10.2 Nipro Corp Business Overview
  58. 8.10.3 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Nipro Corp Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  60. 8.10.5 Nipro Corp Recent Developments
  61. 8.11 Sopharma
  62. 8.11.1 Sopharma Company Information
  63. 8.11.2 Sopharma Business Overview
  64. 8.11.3 Sopharma Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sopharma Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  66. 8.11.5 Sopharma Recent Developments
  67. 8.12 Famar
  68. 8.12.1 Famar Company Information
  69. 8.12.2 Famar Business Overview
  70. 8.12.3 Famar Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Famar Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  72. 8.12.5 Famar Recent Developments
  73. 8.13 Vetter
  74. 8.13.1 Vetter Company Information
  75. 8.13.2 Vetter Business Overview
  76. 8.13.3 Vetter Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Vetter Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  78. 8.13.5 Vetter Recent Developments
  79. 8.14 Shandong Xinhua
  80. 8.14.1 Shandong Xinhua Company Information
  81. 8.14.2 Shandong Xinhua Business Overview
  82. 8.14.3 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shandong Xinhua Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  84. 8.14.5 Shandong Xinhua Recent Developments
  85. 8.15 Piramal
  86. 8.15.1 Piramal Company Information
  87. 8.15.2 Piramal Business Overview
  88. 8.15.3 Piramal Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Piramal Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  90. 8.15.5 Piramal Recent Developments
  91. 8.16 Mylan
  92. 8.16.1 Mylan Company Information
  93. 8.16.2 Mylan Business Overview
  94. 8.16.3 Mylan Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Mylan Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  96. 8.16.5 Mylan Recent Developments
  97. 8.17 Dr. Reddy’s
  98. 8.17.1 Dr. Reddy’s Company Information
  99. 8.17.2 Dr. Reddy’s Business Overview
  100. 8.17.3 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Dr. Reddy’s Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  102. 8.17.5 Dr. Reddy’s Recent Developments
  103. 8.18 Zhejiang Hisun
  104. 8.18.1 Zhejiang Hisun Company Information
  105. 8.18.2 Zhejiang Hisun Business Overview
  106. 8.18.3 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Zhejiang Hisun Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  108. 8.18.5 Zhejiang Hisun Recent Developments
  109. 8.19 Zhejiang Huahai
  110. 8.19.1 Zhejiang Huahai Company Information
  111. 8.19.2 Zhejiang Huahai Business Overview
  112. 8.19.3 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Zhejiang Huahai Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  114. 8.19.5 Zhejiang Huahai Recent Developments
  115. 8.20 Jubilant
  116. 8.20.1 Jubilant Company Information
  117. 8.20.2 Jubilant Business Overview
  118. 8.20.3 Jubilant Pharmaceutical Contract Manufacturing and Contract Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Jubilant Pharmaceutical Contract Manufacturing and Contract Product Portfolio
  120. 8.20.5 Jubilant Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst